K153426 is an FDA 510(k) clearance for the Ox-Imager CS. Classified as Oximeter, Tissue Saturation (product code MUD), Class II - Special Controls.
Submitted by Modulated Imaging, Inc. (Irvine, US). The FDA issued a Cleared decision on December 21, 2016 after a review of 392 days - an unusually long review period, suggesting complex equivalence evaluation.
This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.2700 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.
Device pattern: Standard predicate-based submission. Elevated predicate reliance profile. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.
View all Modulated Imaging, Inc. devices
NCT01484730
Recruiting
Observational
A Pilot Study to Evaluate Multi-Spectral and Laser Speckle Imaging and Multiphoton Microscopy During Vascular Occlusion
A Pilot Study to Evaluate Multi-Spectral Imaging (MI) and Laser Speckle Imaging (LSI) and Multiphoton Microscopy (MPM) During Vascular Occlusion
| Condition studied |
Abnormal Vascular Flow |
| Eligibility |
All sexes
· 18 Years+
· Healthy volunteers accepted
|
| Principal investigator |
Anthony Durkin, PhD |
| Sponsor |
University of California, Irvine
|
Started 2011-11-01
→
Primary completion 2026-08-01
→
Completed 2028-08-01
Primary outcome
Skin blood flow
View full study on ClinicalTrials.gov